The Puerto Rico Senate launched a legislative investigation into the Medical Cannabis Program, evaluating the Department of Health’s oversight processes and compliance with the regulatory framework established by law. On Tuesday, the Senate Health Committee began the first round of site inspections ordered under Senate Resolution 319. Attending were Health Committee Chairman Senator Juan Oscar Morales Rodríguez; Senator Carmelo Ríos Santiago, author of the measure; Senator Migdalia Padilla Alvelo; Department of Health officials; and staff from the Medical Cannabis Regulatory Board (JRCM), led by its executive director, Marjorie Tolentino Rivera.
The Committee inspected the laboratories Cannalytics Bioscience Labs and Novacann Labs Corp., as well as the dispensary Green Health Puerto Rico, to evaluate different stages of the program and observe firsthand the analysis, oversight, and dispensing processes. After the visits, Morales Rodríguez said the inspections helped confirm changes implemented by the Department of Health to strengthen program supervision and verify compliance with corrective measures adopted following administrative actions taken over the past year.
He said he was satisfied with what was observed but noted more work remains.